Miguel Pericacho

1.2k total citations
47 papers, 944 citations indexed

About

Miguel Pericacho is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Nephrology. According to data from OpenAlex, Miguel Pericacho has authored 47 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Nephrology. Recurrent topics in Miguel Pericacho's work include Nitric Oxide and Endothelin Effects (7 papers), Hormonal Regulation and Hypertension (7 papers) and Angiogenesis and VEGF in Cancer (6 papers). Miguel Pericacho is often cited by papers focused on Nitric Oxide and Endothelin Effects (7 papers), Hormonal Regulation and Hypertension (7 papers) and Angiogenesis and VEGF in Cancer (6 papers). Miguel Pericacho collaborates with scholars based in Spain, Czechia and France. Miguel Pericacho's co-authors include José M. López‐Novoa, Carmelo Bernabéu, Alicia Rodríguez‐Barbero, S. Velasco, Fernando Pérez‐Barriocanal, Marta Prieto, Peter ten Dijke, Mirjana Jerkić, Mourad Toporsian and Miguel Arévalo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Circulation Research.

In The Last Decade

Miguel Pericacho

45 papers receiving 935 citations

Peers

Miguel Pericacho

PRM

GENET

ONCOL

Barbara Hertel Germany

Flávia G. Machado Brazil

Susanne Fleig Germany

Goichi Honda Japan

Anne Zufferey Switzerland

Lucas L. Falke Netherlands

Kiyotaka Nagahama Japan

Claudia Schrimpf Germany

Joon Ho Lee South Korea

Eunate Gallardo‐Vara Spain

Barbara Hertel Germany

Miguel Pericacho

504 ×1.3

171 ×0.9

PRM

122 ×0.7

GENET

194 ×1.5

ONCOL

105 ×0.9

Citations per year, relative to Miguel Pericacho Miguel Pericacho (= 1×) peers Barbara Hertel

Countries citing papers authored by Miguel Pericacho

Since Specialization

Citations

This map shows the geographic impact of Miguel Pericacho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miguel Pericacho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miguel Pericacho more than expected).

Fields of papers citing papers by Miguel Pericacho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miguel Pericacho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miguel Pericacho. The network helps show where Miguel Pericacho may publish in the future.

Co-authorship network of co-authors of Miguel Pericacho

This figure shows the co-authorship network connecting the top 25 collaborators of Miguel Pericacho. A scholar is included among the top collaborators of Miguel Pericacho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miguel Pericacho. Miguel Pericacho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pericacho, Miguel, et al.. (2024). Angiogenesis as a Survival Mechanism in Heartworm Disease: The Role of Fructose-Bisphosphate Aldolase and Actin from Dirofilaria immitis in an In Vitro Endothelial Model. Animals. 14(23). 3371–3371.

Pericacho, Miguel, et al.. (2024). Wolbachia Promotes an Anti-Angiogenic Response Using an In Vitro Model of Vascular Endothelial Cells in Relation to Heartworm Disease. Pathogens. 13(7). 603–603. 1 indexed citations

Rossi, Elisa, Miguel Pericacho, Alexandre Kauskot, et al.. (2023). Soluble endoglin reduces thrombus formation and platelet aggregation via interaction with αIIbβ3 integrin. Journal of Thrombosis and Haemostasis. 21(7). 1943–1956. 8 indexed citations

Méndez-García, Lucía Angélica, et al.. (2022). Endoglin and Other Angiogenesis Markers in Recurrent Varicose Veins. Journal of Personalized Medicine. 12(4). 528–528. 4 indexed citations

Hyšpler, Radomı́r, et al.. (2021). High Soluble Endoglin Levels Affect Aortic Vascular Function during Mice Aging. Journal of Cardiovascular Development and Disease. 8(12). 173–173. 1 indexed citations

Méndez-García, Lucía Angélica, et al.. (2021). The Dual Effect of the BMP9–ALK1 Pathway in Blood Vessels: An Opportunity for Cancer Therapy Improvement?. Cancers. 13(21). 5412–5412. 14 indexed citations

Rossi, Elisa, Alexandre Kauskot, François Saller, et al.. (2021). Endoglin Is an Endothelial Housekeeper against Inflammation: Insight in ECFC-Related Permeability through LIMK/Cofilin Pathway. International Journal of Molecular Sciences. 22(16). 8837–8837. 5 indexed citations

Pericacho, Miguel, et al.. (2021). Hot and Cold Tumors: Is Endoglin (CD105) a Potential Target for Vessel Normalization?. Cancers. 13(7). 1552–1552. 30 indexed citations

Najmanová, Iveta, et al.. (2020). Long term effects of soluble endoglin and mild hypercholesterolemia in mice hearts. PLoS ONE. 15(5). e0233725–e0233725. 4 indexed citations

10.

Pericacho, Miguel, Juan A. Rosado, Juan Pons‐Villanueva, & Leire Arbea. (2020). Experiencias de Docencia Virtual en Facultades de Medicina Españolas durante la pandemia COVID-19 (I): Anatomía, Fisiología, Fisiopatología, Oncología. SHILAP Revista de lepidopterología. 1(1). 32–39. 5 indexed citations

11.

Hroch, M, Radomı́r Hyšpler, Alena Tichá, et al.. (2020). Soluble Endoglin as a Potential Biomarker of Nonalcoholic Steatohepatitis (NASH) Development, Participating in Aggravation of NASH-Related Changes in Mouse Liver. International Journal of Molecular Sciences. 21(23). 9021–9021. 10 indexed citations

12.

Díaz‐Rodríguez, Elena, et al.. (2020). Continuous endoglin (CD105) overexpression disrupts angiogenesis and facilitates tumor cell metastasis. Angiogenesis. 23(2). 231–247. 30 indexed citations

13.

Rodríguez‐Barbero, Alicia, et al.. (2020). Pregnancy-Induced High Plasma Levels of Soluble Endoglin in Mice Lead to Preeclampsia Symptoms and Placental Abnormalities. International Journal of Molecular Sciences. 22(1). 165–165. 21 indexed citations

14.

Gallardo‐Vara, Eunate, José Luis Bartha, Irene García‐Palmero, et al.. (2020). Potential Role of Circulating Endoglin in Hypertension via the Upregulated Expression of BMP4. Cells. 9(4). 988–988. 25 indexed citations

15.

Najmanová, Iveta, Eva Doleželová, Ivana Němečková, et al.. (2018). Soluble endoglin and hypercholesterolemia aggravate endothelial and vessel wall dysfunction in mouse aorta. Atherosclerosis. 271. 15–25. 31 indexed citations

16.

Rathouska, Jana, Eva Doleželová, Ivana Němečková, et al.. (2017). High soluble endoglin levels do not induce changes in structural parameters of mouse heart. Heart and Vessels. 32(8). 1013–1024. 5 indexed citations

17.

Pérez‐Barriocanal, Fernando, et al.. (2017). Circulating soluble endoglin modifies the inflammatory response in mice. PLoS ONE. 12(11). e0188204–e0188204. 16 indexed citations

18.

Calzada, Nuria, Consuelo González‐Manchón, Miguel Pericacho, et al.. (2012). C3G transgenic mouse models with specific expression in platelets reveal a new role for C3G in platelet clotting through its GEF activity. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1823(8). 1366–1377. 14 indexed citations

19.

Cruz‐González, Ignacio, Pedro Pabón, Alicia Rodríguez‐Barbero, et al.. (2008). Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction. Journal of Cellular and Molecular Medicine. 12(3). 955–961. 40 indexed citations

20.

Ocaña, Alberto, Alicia Rodríguez‐Barbero, Miguel Pericacho, et al.. (2007). Human recombinant erythropoietic agents do not induce changes in circulating levels of endoglin and vascular endothelial growth factor in anemic cancer patients. Cancer Letters. 255(1). 71–76. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact